Craniosynostosis (CS) has a prevalence of approximately 1 in every 2000 live births and is characterized by the premature fusion of one or more cranial sutures. Failure to maintain the cell lineage boundary at the coronal suture is thought to be involved in the pathology of some forms of CS. The Ephrin family of receptor tyrosine kinases consists of membrane-bound receptors and ligands that control cell patterning and the formation of developmental boundaries. Mutations in the ephrin A4 (EFNA4) and ephrin B1 (EFNB1) ligands have been linked to nonsyndromic CS and craniofrontonasal syndrome, respectively, in patient samples. We have previously described a colony of rabbits with a heritable pattern of coronal suture synostosis, although the genetic basis for synostosis within this model remains unknown. The present study was performed to determine if EFNA4 or EFNB1 could be the loci of the causal mutation in this unique animal model. Sequencing of EFNA4 and EFNB1 was performed using templates obtained from wild-type (n ¼ 4) and craniosynostotic (n ¼ 4) rabbits. No structural coding errors were identified in either gene. A single-nucleotide transversion was identified in one wild-type rabbit within the third intron of EFNA4. These data indicate that the causal locus for heritable CS in this rabbit model is not located within the structural coding regions of either EFNA4 or EFNB1.
. The severity of craniofacial growth and ocular and neural abnormalities associated with CS poses extensive and often recurring clinical and surgical management problems.
The etiopathology of CS is multifactorial and poorly understood. Approximately 180 syndromes have been described, and mutations in more than 45 distinct genes have been causally linked to CS, although the genetic basis for disease remains unknown in~80% of patient cases (Heuze et al., 2014) . Approximately 25% of all patient cases with a known etiology involve mutations within coding regions of the FGFR2, FGFR3, Twist1, TCF12, and EFNB1 genes (Wilkie et al., 2010; Paumard-Hernandez et al., 2015) . Mutations affecting the FGFRs account for more than 50% of all cases of CS for which a genetic determinant has been identified. Mutations that affect the Twist1 basic helixloop-helix (bHLH) transcription factor are frequently associated with Saethre-Chotzen syndrome (el Ghouzzi et al., 1997; Howard et al., 1997) , whereas mutations that affect the TCF12 bHLH transcription factor have been linked to coronal synostosis (Sharma et al., 2013) . Mutations affecting the EFNA4 and EFNB1 ligands have been linked to nonsyndromic CS (Merrill et al., 2006; Johnson and Wilkie, 2011) and craniofrontonasal syndrome (Twigg et al., 2004 , Wieland et al., 2004 , respectively.
The Ephrin family of receptor tyrosine kinases consists of two receptor subclasses, the EphA receptors and the EphB receptors, which are primarily distinguished by virtue of their interaction with A-type ligands or B-type ligands (Lisabeth et al., 2013; Cayuso et al., 2015) . EphrinA ligands are bound to the extracellular cell membrane via a glycosylphosphatidylinositol anchor, whereas ephrinB ligands are transmembrane proteins with a cytoplasmic tail. Eph/ephrin interactions mediate contact-dependent communication between cells in a bidirectional manner, through both the receptor-expressing and the ligand-expressing cells, to regulate cellular adhesion, movement, proliferation, survival, and differentiation (Lisabeth et al., 2013; Cayuso et al., 2015) . During development, these activities determine the spatial organization of cell populations by directing cell migration to appropriate targets and by inhibiting inappropriate mixing of distinct cell lineages within developing tissues. EphB/ ephrinB1 interactions, in particular, are known to regulate skeletal patterning and craniofacial morphogenesis (Compagni et al., 2003; Bush and Soriano, 2010) , and errors in Eph/ephrin signaling have been shown to cause CS in knockout mouse models as a result of inappropriate cell lineage mixing within the coronal suture (Twigg et al., 2004; Merrill et al., 2006; Ting et al., 2009) . Dominant mutations in EFNA4 and EFNB1 have also been identified in patients with CS (Merrill et al., 2006; Wallis et al., 2008) .
We have previously described a rabbit model with congenital CS (Mooney et al., 1994a (Mooney et al., , 1994b (Mooney et al., , 1996 (Mooney et al., , 2000 (Mooney et al., , 2002 . Similar to humans, this colony of affected New Zealand White rabbits demonstrates autosomal dominant transmission with variable phenotypic expression (Mooney et al., 1994b (Mooney et al., , 1996 (Mooney et al., , 2000 (Mooney et al., , 2002 Gilbert et al., in press) . The animals present with a broad range of phenotypic expression for the isolated coronal suture synostosis pathology, including unilaterally affected animals, animals with delayed-onset (i.e., postnatal) suture synostosis, and animals with early-onset (i.e., prenatal) complete bilateral fusion (Mooney et al., 1998a (Mooney et al., , 1998b Gilbert et al., in press) . A small subset of these rabbits have also presented with interfrontal suture synostosis and frontonasal sutural dysplasia, both suggestive of craniofrontonasal syndrome (Mooney et al., 2000 (Mooney et al., , 2002 . However, the genetic defect within this rabbit model is unknown, and a lack of commercial tools specific to the rabbit has made mapping genetic defects problematic. We have previously excluded FGFR1-3 and Twist1 as the likely causal loci for synostosis within the CS rabbit (Gallo et al., 2013 (Gallo et al., , 2014 . Therefore, this study was performed to determine whether structural mutations that alter the protein coding sequence of EFNB1 or EFNA4 might be causally linked to CS within our naturally occurring rabbit model.
MATERIALS AND METHODS

Tissue Samples
Tissues including skin and kidney samples were collected from wild type (n ¼ 4) and CS (n ¼ 4) New Zealand White rabbits (Oryctolagus cuniculus) during routine culling of the colony in the present study. The CS rabbits used in this study exhibit an early-onset phenotype with complete bilateral fusion of the coronal suture by 10 days of age and secondary changes in the cranial base, brain, and intracranial volume (Mooney et al., 1994a (Mooney et al., , 1994b . Morphologically, the synostosed rabbits from this colony are very similar to human infants with early-onset CS. Wild-type rabbits were obtained through Charles Rivers Laboratories and were bred to produce control litters. All CS rabbits were born in our breeding colony of congenitally synostosed rabbits at the University of Pittsburgh, Department of Plastic Surgery, vivarium. This study was reviewed and approved by the University of Pittsburgh, Institutional Animal Care and Use Committee.
Genomic DNA Isolation
Skin samples (~50 mg/animal) were suspended in 1 mL freshly prepared lysis buffer (10 mM Tris-HCl [pH 8.0], 100 mM NaCl, 10 mM EDTA [pH 8.0], 1% sodium dodecyl sulfate, 0.4 mg/mL proteinase K) and were incubated at 65 8C overnight. The following day, samples were homogenized using a Biomasher II micro-homogenizer (Polysciences Inc., Warrington, PA). Homogenates were sequentially extracted with buffer-saturated phenol and chloroform. The aqueous phase was collected and transferred to a tube containing 2.5 volumes 95% ethanol. Samples were mixed by gentle inversion to minimize chromosomal shearing. Flocculent DNA precipitates were collected by spooling onto a sterile micropipette tip and were transferred to a fresh tube. Genomic DNA samples were resuspended in TE buffer (10 mM Tris-HCl [pH 7.4], 1 mM EDTA [pH 8.0]) at a final concentration of 1 mg/mL as determined by spectrophotometry.
RNA Isolation and First-Strand cDNA Synthesis
Kidney samples (~50 mg/animal) were pulverized under liquid nitrogen using a BioPulverizer (BioSpec Products, Bartlesville, OK). Pulverized tissues were subsequently homogenized using a Biomasher II micro-homogenizer in 1 mL Trizol (Thermo Fisher Scientific, Grand Island, NY) reagent. Total RNA was precipitated according to the manufacturer's protocol. RNA precipitates were resuspended in 100 lL Qiagen's RLT buffer and were column purified using the RNeasy Micro Kit (Qiagen, Valencia, CA) according to the manufacturer's protocol. Purified RNA was eluted in a final volume of 50 lL DEPC-treated dH 2 0.
First-strand cDNA synthesis was performed using the Accuscript Hi-Fi cDNA Synthesis Kit (Agilent Technologies, Santa Clara, CA) according to the manufacturer's protocol. First-strand cDNA synthesis reactions were performed using~1.5 to 5 lg purified RNA as template with an oligo(dT) primer. Incubations were performed for two hours at 428C. Reactions were terminated by heat inactivation at 708C for 15 minutes, and samples were stored at À808C until use.
Polymerase Chain Reaction Amplification and Gel Purification
Amplification of genomic exons encoding for EF-NA4 (GenBank Accession: NC_013681.1) and EFNB1 (GenBank Accession: NC_013690.1) were performed using the Q5 High Fidelity DNA Polymerase (New England Biolabs, Ipswich, MA) and 1 lg genomic DNA as template in a 25 lL reaction. Primer sets spanning the exons encoding for EFNA4 and EFNB1 are presented in Table 1 . Polymerase chain reaction (PCR) conditions for genomic templates consisted of (1) an initial denaturation at 988C for 30 seconds; (2) 35 cycles of denaturation at 988C for 10 seconds, annealing at 608C for 20 seconds, and extension at 728C for 10 to 15 seconds; and (3) a final extension at 728C for 20 seconds. Amplification of EFNA4 and EFNB1 cDNA templates were performed using the Q5 High Fidelity DNA Polymerase (New England Biolabs) and 1 lL cDNA as template in a 25 lL reaction. Primer sets spanning the EFNA4 cDNA (GenBank Accession: XM_008264361.1) and EFNB1 cDNA (GenBank Accession: XM_002720061.2) are presented in Table 1 . PCR conditions for cDNA templates consisted of (1) an initial denaturation at 988C for 30 seconds; (2) 45 cycles of denaturation at 988C for 10 seconds, annealing at 658C for 20 seconds, and extension at 728C for 20 to 30 seconds; and (3) a final extension at 728C for 45 seconds.
PCR products were separated on 2.0% agarose gels in 1x TAE buffer containing 1 lg/mL ethidium bromide using an Owl Wide Gel Electrophoresis System (Thermo Fisher Scientific). A 2-log DNA Standard (New England Biolabs) was included in all gels. Products were visualized under ultraviolet (UV) light, and appropriately-sized products were excised from the gel using a clean cover slip. Isolated bands were purified using the Silica Bead DNA Gel Extraction Kit (Thermo Fisher Scientific) according to the manufacturer's protocol.
Sequencing
PCR products mixed with either forward or reverse sequencing primers (Table 1) were submitted to GENEWIZ (South Plainfield, NJ) for sequencing. Sequencing alignments were performed using Clustal Omega (EMBL-EBI, Cambridge, UK). Chromatograms were visually inspected using Chromas v.2.5.1 Software (Technelysium, South Brisbane, Australia) for validation of sequencing results.
RESULTS
We have previously described the extensive phenotypic variability that is observed within the CS rabbit colony. This variability ranges from normal coronal suture morphology and normal craniofacial, skeletal, and somatic growth to abnormal unilateral or bilateral coronal suture morphology with postnatal or delayed-onset coronal suture synostosis and slightly altered craniofacial growth to complete obliterated unilateral or bilateral coronal sutures with prenatal or early onset with subsequent craniofacial deformations (Mooney et al., 1994a (Mooney et al., , 1994b Gilbert et al., in press ). The synostotic animals used in this study exhibit the most severe form, with the early-onset of coronal suture fusion being evident at 10 days of age.
We initially sequenced the four coding exons of EFNA4 and the five coding exons of EFNB1 to identify potential structural coding mutations within either gene (Fig. 1) . Sequencing of EFNA4 revealed no structural variants in either wild-type or CS rabbits when compared with the published genome assembly for the Thorbecke rabbit strain (Orycun 2.0, Ensembl release 84). A single T.A nucleotide transversion was identified at chromosomal position 37,600,221 immediately flanking exon 4 of EFNA4. This variant failed to segregate by phenotype and was detected in a sole wild-type rabbit. Sequencing of EFNB1 revealed no structural variants in either wild-type or CS rabbits when compared with the OryCun 2.0 genome assembly.
To rule out the possibility of splicing errors, full-length EFNA4 and EFNB1 cDNAs were amplified from kidney samples. When visualized under UV light, the size of the PCR products correlated with the predicted size of EFNA4 (615 nucleotides) and EFNB1 (1047 nucleotides). Sequencing of cDNA templates confirmed that splicing occurred as predicted for both genes.
DISCUSSION
The craniosynostotic rabbit is useful because it remains the only naturally occurring large animal model for CS (Mooney et al., 2002; Holmes, 2012) . More importantly, it has proven to be useful for evaluating biological therapies targeted against both primary fusion of the coronal suture FIGURE 1 The genomic architecture of chromosomal regions coding for EFNA4 and EFNB1 are depicted in line art. The relative positions of primer pairs used for PCR amplification and sequencing are identified using arrows in the forward () and reverse () orientations and are labeled as forward (F) or reverse (R) sequences. A 40-nucleotide region spanning intron 3 and exon 4 of EFNA4 is shown in color and highlights the single-nucleotide polymorphism identified in this study. The sequences displayed include representative samples for each phenotype as well as the predicted sequence for the region as defined in Ensembl, release version 83. The splice acceptor (sa) site is labeled. Full-length cDNA products for EFNA4 and EFNB1 were subjected to agarose gel electrophoresis and are shown at the bottom of the figure. The size of the products correlates with predicted values and confirms the proper splicing of both the EFNA4 and EFNB1 transcripts.
and postoperative reossification following surgical management of the disease (Chong et al., 2003; Cooper et al., 2007; Mooney et al., 2007a Mooney et al., , 2007b Cooper et al., 2009; Cray et al., 2010 Cray et al., , 2011 Gilbert et al., 2016) . The utility of the CS rabbit as a model organism has been limited, however, by the paucity of data concerning its genetic etiology. Our laboratory is currently in the midst of trying to identify the gene or genes responsible for CS in this rabbit model by sequencing of known candidate genes that contribute to CS in humans as well as using bioinformatic approaches to identify potentially novel causal loci in this large animal model.
In the present study, we chose to examine only the most severely affected population of rabbits with an early-onset phenotype. While previous studies have indicated the likely presence of a modifying locus within the colony, pedigree analysis indicates that this modifying locus would be present only within the early-onset population of rabbits (Gilbert et al., in press ). The less severely affected delayed-onset population would necessarily lack the modifying allele or express the modifying allele as a heterozygous recessive mutation. Thus, we examined only the most severely affected population of rabbits because this population would be the most likely to express genetic aberrations linked to CS.
The mutations most frequently linked to CS in patients involve the genes encoding for FGFR2, FGFR3, the Twist1 and TCF12 bHLH transcription factors, and EFNB1 (Wilkie et al., 2010; Paumard-Hernandez et al., 2015) . Mutations in EFNA4 have been associated with nonsyndromic CS with lesser frequency (Merrill et al., 2006) . We have previously excluded FGFR1-3 and Twist1 as the likely causal loci for synostosis within the CS rabbit colony. In this study, we have excluded EFNA4 and EFNB1 as the likely causal loci for CS in our rabbit model. Thus, we have excluded all of the genes most frequently associated with CS in patients, with the sole exception of TCF12. Future studies will evaluate TCF12 as part of a larger body of work focused on transcription factors that have been associated with CS in patients.
It remains possible that gene duplication or promoter alterations might affect the function of EFNA4 or EFNB1 in the CS rabbit. We consider this an unlikely possibility, though, because ephrin mutations in patients with CS have invariably involved structural coding errors that affect Eph/ ephrin binding or multimerization. There remain other candidate genes to examine in this rabbit system to determine the basis of the disease phenotype, but it is also possible that the phenotype displayed by these animals is derived from an as yet unrecognized genetic locus. Further investigation to identify the fundamental genetic defect in these animals will hopefully shed light into the molecular mechanisms underlying CS and possibly point the way to new interventions.
